Back D J, Grimmer S F, Shenoy N, Orme M L
Department of Pharmacology and Therapeutics, University of Liverpool.
Contraception. 1987 Jun;35(6):619-26. doi: 10.1016/s0010-7824(87)80021-5.
The plasma concentrations of 3-keto-desogestrel have been measured by radioimmunoassay in a crossover study in nine healthy female volunteers given oral desogestrel (150 micrograms) and ethinyloestradiol (30 micrograms) and intravenous (i.v.) 3-keto-desogestrel (150 micrograms) and ethinyloestradiol (30 micrograms). Bioavailability ranged between 40.0 and 113% with a mean value ( +/- SD) of 76.1 +/- 22.5%. Only 3 subjects had a bioavailability of less than 70%. There was no significant difference in the elimination half life of 3-keto-desogestrel which was 12.6 +/- 4.1h following i.v. administration and 11.9 +/- 4.1h after oral administration of desogestrel.
在一项交叉研究中,对9名健康女性志愿者进行了检测,这些志愿者口服去氧孕烯(150微克)和炔雌醇(30微克),静脉注射3-酮-去氧孕烯(150微克)和炔雌醇(30微克),然后通过放射免疫分析法测定3-酮-去氧孕烯的血浆浓度。生物利用度在40.0%至113%之间,平均值(±标准差)为76.1±22.5%。只有3名受试者的生物利用度低于70%。3-酮-去氧孕烯的消除半衰期在静脉注射后为12.6±4.1小时,口服去氧孕烯后为11.9±4.1小时,两者之间无显著差异。